MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
Management of the Company will host a conference call to discuss the firstquarter financial results, clinical progress and other Company developments at5:00 p.m. EDT on Monday, May 5, 2008. Presenting from the Company will be itsChairman and Chief Executive Officer, Alfred Mann; President and ChiefOperating Officer, Hakan Edstrom; Corporate Vice President and Chief FinancialOfficer, Matthew Pfeffer and Corporate Vice President and Chief ScientificOfficer, Peter Richardson.
To participate in the live call by telephone, please dial (800) 857-0373or (210) 839-8507. Those interested in listening to the conference call livevia the Internet may do so by visiting the Company's website athttp://www.mannkindcorp.com.
A telephone replay of the call will be accessible for approximatelyfourteen days following completion of the call by dialing (866) 457-6651 or(203) 369-1300. A replay will also be available on MannKind's website forfourteen days.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, developmentand commercialization of therapeutic products for diseases such as diabetesand cancer. Its lead product, the Technosphere(R) Insulin System, is currentlyin Phase 3 clinical trials in the United States, Europe and Latin America tostudy its safety and efficacy in the treatment of diabetes. For moreinformation on MannKind Corporation and its technology, visithttp://www.mannkindcorp.com.
SOURCE MannKind Corporation
You May Also Like